<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">34237471</PMID><DateCompleted><Year>2021</Year><Month>09</Month><Day>08</Day></DateCompleted><DateRevised><Year>2024</Year><Month>08</Month><Day>14</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">1530-891X</ISSN><JournalIssue CitedMedium="Print"><Volume>27</Volume><Issue>9</Issue><PubDate><Year>2021</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists</Title><ISOAbbreviation>Endocr Pract</ISOAbbreviation></Journal><ArticleTitle>Long COVID in Patients With Mild to Moderate Disease: Do Thyroid Function and Autoimmunity Play a Role?</ArticleTitle><Pagination><StartPage>894</StartPage><EndPage>902</EndPage><MedlinePgn>894-902</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.eprac.2021.06.016</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1530-891X(21)01111-3</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">Post-acute sequelae of coronavirus disease 2019 (COVID-19) or long COVID (LC) is an emerging global health issue. Fatigue is a common feature. Whether thyroid function and autoimmunity play a role is uncertain. We aimed to evaluate the prevalence and predictors of LC and the potential role of thyroid function and autoimmunity in LC.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We included consecutive adults without a known thyroid disorder who were admitted to a major COVID-19 center for confirmed COVID-19 from July to December 2020. Thyroid function tests and antithyroid antibodies were measured for all patients on admission and at follow-up. LC was defined by the presence or persistence of symptoms upon follow-up.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">In total, 204 patients (median age, 55.0 years; 95 men [46.6%]) were reassessed at a median of 89 days (interquartile range, 69-99) after acute COVID-19. Of the 204 patients, 41 (20.1%) had LC. Female sex (adjusted odds ratio, 2.48; P&#xa0;= .018) and severe acute respiratory syndrome coronavirus 2 polymerase chain reaction cycle threshold value of &lt;25 on admission (adjusted odds ratio, 2.84; P&#xa0;= .012) independently predicted the occurrence of LC. Upon follow-up, most abnormal thyroid function tests in acute COVID-19 resolved, and incident thyroid dysfunction was rare. Nonetheless, we observed incident antithyroid peroxidase (anti-TPO) positivity. Although baseline or follow-up thyroid function tests were not associated with the occurrence of LC, among 172 patients with symptomatic acute COVID-19, symptom resolution was more likely in those with positive anti-TPO upon follow-up (P&#xa0;= .043).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">LC is common among COVID-19 survivors, with females and those with higher viral load in acute COVID-19 particularly being vulnerable. The observation of incident anti-TPO positivity warrants further follow-up for thyroid dysfunction. Whether anti-TPO plays a protective role in LC remains to be elucidated.</AbstractText><CopyrightInformation>Copyright &#xa9; 2021 AACE. Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lui</LastName><ForeName>David Tak Wai</ForeName><Initials>DTW</Initials><AffiliationInfo><Affiliation>Department of Medicine, The University of Hong Kong, Queen Mary Hospital, Hong Kong, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Chi Ho</ForeName><Initials>CH</Initials><AffiliationInfo><Affiliation>Department of Medicine, The University of Hong Kong, Queen Mary Hospital, Hong Kong, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chow</LastName><ForeName>Wing Sun</ForeName><Initials>WS</Initials><AffiliationInfo><Affiliation>Department of Medicine, The University of Hong Kong, Queen Mary Hospital, Hong Kong, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Alan Chun Hong</ForeName><Initials>ACH</Initials><AffiliationInfo><Affiliation>Department of Medicine, The University of Hong Kong, Queen Mary Hospital, Hong Kong, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tam</LastName><ForeName>Anthony Raymond</ForeName><Initials>AR</Initials><AffiliationInfo><Affiliation>Department of Medicine, The University of Hong Kong, Queen Mary Hospital, Hong Kong, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pang</LastName><ForeName>Polly</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Medicine, The University of Hong Kong, Queen Mary Hospital, Hong Kong, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ho</LastName><ForeName>Tip Yin</ForeName><Initials>TY</Initials><AffiliationInfo><Affiliation>Department of Medicine, The University of Hong Kong, Queen Mary Hospital, Hong Kong, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fong</LastName><ForeName>Carol Ho Yi</ForeName><Initials>CHY</Initials><AffiliationInfo><Affiliation>Department of Medicine, The University of Hong Kong, Queen Mary Hospital, Hong Kong, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Law</LastName><ForeName>Chun Yiu</ForeName><Initials>CY</Initials><AffiliationInfo><Affiliation>Division of Chemical Pathology, Queen Mary Hospital, Hong Kong, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Leung</LastName><ForeName>Eunice Ka Hong</ForeName><Initials>EKH</Initials><AffiliationInfo><Affiliation>Department of Medicine, The University of Hong Kong, Queen Mary Hospital, Hong Kong, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>To</LastName><ForeName>Kelvin Kai Wang</ForeName><Initials>KKW</Initials><AffiliationInfo><Affiliation>Department of Microbiology, The University of Hong Kong, Queen Mary Hospital, Hong Kong, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tan</LastName><ForeName>Kathryn Choon Beng</ForeName><Initials>KCB</Initials><AffiliationInfo><Affiliation>Department of Medicine, The University of Hong Kong, Queen Mary Hospital, Hong Kong, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Woo</LastName><ForeName>Yu Cho</ForeName><Initials>YC</Initials><AffiliationInfo><Affiliation>Department of Medicine, The University of Hong Kong, Queen Mary Hospital, Hong Kong, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lam</LastName><ForeName>Ching Wan</ForeName><Initials>CW</Initials><AffiliationInfo><Affiliation>Department of Pathology, The University of Hong Kong, Hong Kong, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hung</LastName><ForeName>Ivan Fan Ngai</ForeName><Initials>IFN</Initials><AffiliationInfo><Affiliation>Department of Medicine, The University of Hong Kong, Queen Mary Hospital, Hong Kong, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lam</LastName><ForeName>Karen Siu Ling</ForeName><Initials>KSL</Initials><AffiliationInfo><Affiliation>Department of Medicine, The University of Hong Kong, Queen Mary Hospital, Hong Kong, China. Electronic address: ksllam@hku.hk.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>07</Month><Day>06</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Endocr Pract</MedlineTA><NlmUniqueID>9607439</NlmUniqueID><ISSNLinking>1530-891X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015551" MajorTopicYN="Y">Autoimmunity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013961" MajorTopicYN="N">Thyroid Gland</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">autoantibodies</Keyword><Keyword MajorTopicYN="N">autoimmunity</Keyword><Keyword MajorTopicYN="N">post&#x2013;acute COVID-19 syndrome</Keyword><Keyword MajorTopicYN="N">thyroid function tests</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>5</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>6</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>6</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>7</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>9</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>7</Month><Day>8</Day><Hour>20</Hour><Minute>15</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>7</Month><Day>6</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34237471</ArticleId><ArticleId IdType="pmc">PMC8257401</ArticleId><ArticleId IdType="doi">10.1016/j.eprac.2021.06.016</ArticleId><ArticleId IdType="pii">S1530-891X(21)01111-3</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Hu B., Guo H., Zhou P., Shi Z.L. Characteristics of SARS-CoV-2 and COVID-19. Nat Rev Microbiol. 2021;19(3):141&#x2013;154.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7537588</ArticleId><ArticleId IdType="pubmed">33024307</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalbandian A., Sehgal K., Gupta A. Post-acute COVID-19 syndrome. Nat Med. 2021;27(4):601&#x2013;615.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8893149</ArticleId><ArticleId IdType="pubmed">33753937</ArticleId></ArticleIdList></Reference><Reference><Citation>Rando HM, Bennett TD, Byrd JB, et&#xa0;al. Challenges in defining long COVID: striking differences across literature, Electronic Health Records, and patient-reported information. Preprint. Posted online March 26, 2021. medRxiv 21253896. https://doi.org/10.1101/2021.03.20.21253896</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.03.20.21253896</ArticleId></ArticleIdList></Reference><Reference><Citation>Amenta E.M., Spallone A., Rodriguez-Barradas M.C., Sahly H.M.E., Atmar R.L., Kulkarni P.A. Postacute covid-19: an overview and approach to classification. Open Forum Infect Dis. 2020;7(12):ofaa509.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7665635</ArticleId><ArticleId IdType="pubmed">33403218</ArticleId></ArticleIdList></Reference><Reference><Citation>Murray T. Unpacking &#x201c;long COVID.&#x201d;. CMAJ. 2021;193(9):E318&#x2013;E319.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8034303</ArticleId><ArticleId IdType="pubmed">33649174</ArticleId></ArticleIdList></Reference><Reference><Citation>Gupta A., Madhavan M.V., Sehgal K. Extrapulmonary manifestations of COVID-19. Nat Med. 2020;26(7):1017&#x2013;1032.</Citation><ArticleIdList><ArticleId IdType="pubmed">32651579</ArticleId></ArticleIdList></Reference><Reference><Citation>Lisco G, De Tullio A, Jirillo E, et&#xa0;al. Thyroid and COVID-19: a review on pathophysiological, clinical and organizational aspects. J Endocrinol Invest. Published online March 25, 2021. https://doi.org/10.1007/s40618-021-01554-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40618-021-01554-z</ArticleId><ArticleId IdType="pmc">PMC7992516</ArticleId><ArticleId IdType="pubmed">33765288</ArticleId></ArticleIdList></Reference><Reference><Citation>Lui DTW, Lee CH, Chow WS, et&#xa0;al. Insights from a prospective follow-up of thyroid function and autoimmunity among COVID-19 survivors. Endocrinol Metab (Seoul). Published online June 8, 2021. https://doi.org/10.3803/EnM.2021.983</Citation><ArticleIdList><ArticleId IdType="doi">10.3803/EnM.2021.983</ArticleId><ArticleId IdType="pmc">PMC8258341</ArticleId><ArticleId IdType="pubmed">34107601</ArticleId></ArticleIdList></Reference><Reference><Citation>Galeotti C., Bayry J. Autoimmune and inflammatory diseases following COVID-19. Nat Rev Rheumatol. 2020;16(8):413&#x2013;414.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7271827</ArticleId><ArticleId IdType="pubmed">32499548</ArticleId></ArticleIdList></Reference><Reference><Citation>Lui DTW, Lee CH, Chow WS, et&#xa0;al. Role of non-thyroidal illness syndrome in predicting adverse outcomes in COVID-19 patients predominantly of mild-to-moderate severity. Clin Endocrinol (Oxf). Published online April 4, 2021. https://doi.org/10.1111/cen.14476</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/cen.14476</ArticleId><ArticleId IdType="pmc">PMC8250365</ArticleId><ArticleId IdType="pubmed">33813743</ArticleId></ArticleIdList></Reference><Reference><Citation>Lui D.T.W., Lee C.H., Chow W.S. Thyroid dysfunction in relation to immune profile, disease status, and outcome in 191 patients with COVID-19. J&#xa0;Clin Endocrinol Metab. 2021;106(2):e926&#x2013;e935.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7665541</ArticleId><ArticleId IdType="pubmed">33141191</ArticleId></ArticleIdList></Reference><Reference><Citation>Eknoyan G., Lameire N., Eckardt K. Definition and classification of CKD. In: KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int Suppl. 2013;3(1):5&#x2013;14.</Citation></Reference><Reference><Citation>Litmanovich D.E., Chung M., Kirkbride R.R., Kicska G., Kanne J.P. Review of chest radiograph findings of COVID-19 pneumonia and suggested reporting language. J&#xa0;Thorac Imaging. 2020;35(6):354&#x2013;360.</Citation><ArticleIdList><ArticleId IdType="pubmed">32520846</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu F., Yan L., Wang N. Quantitative detection and viral load analysis of SARS-CoV-2 in infected patients. Clin Infect Dis. 2020;71(15):793&#x2013;798.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7184442</ArticleId><ArticleId IdType="pubmed">32221523</ArticleId></ArticleIdList></Reference><Reference><Citation>Tom M.R., Mina M.J. To interpret the SARS-CoV-2 test, consider the cycle threshold value. Clin Infect Dis. 2020;71(16):2252&#x2013;2254.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7314112</ArticleId><ArticleId IdType="pubmed">32435816</ArticleId></ArticleIdList></Reference><Reference><Citation>Chinese clinical guidance for COVID-19 pneumonia diagnosis and treatment (7th edition). Accessed August 23, 2020. http://kjfy.meetingchina.org/msite/news/show/cn/3337.html</Citation></Reference><Reference><Citation>To K.K.W., Tsang O.T.Y., Leung W.S. Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study. Lancet Infect Dis. 2020;20(5):565&#x2013;574.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7158907</ArticleId><ArticleId IdType="pubmed">32213337</ArticleId></ArticleIdList></Reference><Reference><Citation>British Society of Thoracic Imaging post-COVID-19 CXR report codes. Accessed&#xa0;August 14, 2021. https://www.bsti.org.uk/media/resources/files/BSTI_PostCOVIDCXRtemplatefinal.28.05.201.pdf</Citation></Reference><Reference><Citation>Lau W.C.Y., Chan E.W., Cheung C.L. Association between dabigatran vs warfarin and risk of osteoporotic fractures among patients with nonvalvular atrial fibrillation. JAMA. 2017;317(11):1151&#x2013;1158.</Citation><ArticleIdList><ArticleId IdType="pubmed">28324091</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee CH, Lui DTW, Cheung CYY, et&#xa0;al. Different glycaemia-related risk factors for incident Alzheimer&#x2019;s disease in men and women with type 2 diabetes-a sex-specific analysis of the Hong Kong diabetes database. Diabetes Metab Res Rev. Published online September 1, 2020. https://doi.org/10.1002/dmrr.3401</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/dmrr.3401</ArticleId><ArticleId IdType="pubmed">32870568</ArticleId></ArticleIdList></Reference><Reference><Citation>Lui D.T.W., Lee C.H., Chan Y.H. HbA1c variability, in addition to mean HbA1c, predicts incident hip fractures in Chinese people with type 2 diabetes. Osteoporos Int. 2020;31(10):1955&#x2013;1964.</Citation><ArticleIdList><ArticleId IdType="pubmed">32385660</ArticleId></ArticleIdList></Reference><Reference><Citation>Lui D.T.W., Lee C.H., Tang V. Thyroid immune-related adverse events in patients with cancer treated with anti-PD1/anti-CTLA4 immune checkpoint inhibitor combination: clinical course and outcomes. Endocr Pract. 2021;27(9):886&#x2013;893.</Citation><ArticleIdList><ArticleId IdType="pubmed">33581327</ArticleId></ArticleIdList></Reference><Reference><Citation>Rao S.N., Manissero D., Steele V.R., Pareja J. A&#xa0;systematic review of the clinical utility of cycle threshold values in the context of COVID-19. Infect Dis Ther. 2020;9(3):573-586. Published correction appears in Infect Dis Ther. 2020;9(3):587.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7431897</ArticleId><ArticleId IdType="pubmed">32809140</ArticleId></ArticleIdList></Reference><Reference><Citation>Meagher T. Long COVID&#x2014;an early perspective. J&#xa0;Insur Med. 2021;49(1):19&#x2013;23.</Citation><ArticleIdList><ArticleId IdType="pubmed">33784738</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Z., McGoogan J.M. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in china: summary of a report of 72&#xa0;314 cases from the Chinese Center for Disease Control and Prevention. JAMA. 2020;323(13):1239&#x2013;1242.</Citation><ArticleIdList><ArticleId IdType="pubmed">32091533</ArticleId></ArticleIdList></Reference><Reference><Citation>Sudre C.H., Murray B., Varsavsky T. Attributes and predictors of long COVID. Nat Med. 2021;27(4):626-631. Published correction appears in Nat Med. 2021;27(6):1116.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7611399</ArticleId><ArticleId IdType="pubmed">33692530</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiong Q., Xu M., Li J. Clinical sequelae of COVID-19 survivors in Wuhan, China: a single-centre longitudinal study. Clin Microbiol Infect. 2021;27(1):89&#x2013;95.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7510771</ArticleId><ArticleId IdType="pubmed">32979574</ArticleId></ArticleIdList></Reference><Reference><Citation>Troyer E.A., Kohn J.N., Hong S. Are we facing a crashing wave of neuropsychiatric sequelae of COVID-19? Neuropsychiatric symptoms and potential immunologic mechanisms. Brain Behav Immun. 2020;87:34&#x2013;39.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7152874</ArticleId><ArticleId IdType="pubmed">32298803</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilson C. Concern coronavirus may trigger post-viral fatigue syndromes. New Sci. 2020;246(3278):10&#x2013;11.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7194715</ArticleId><ArticleId IdType="pubmed">32372811</ArticleId></ArticleIdList></Reference><Reference><Citation>Mendelson M., Nel J., Blumberg L. Long-COVID: an evolving problem with an extensive impact. S&#xa0;Afr Med J. 2020;111(1):10&#x2013;12.</Citation><ArticleIdList><ArticleId IdType="pubmed">33403997</ArticleId></ArticleIdList></Reference><Reference><Citation>Siriwardhane T., Krishna K., Ranganathan V. Significance of anti-TPO as an early predictive marker in thyroid disease. Autoimmune Dis. 2019;2019:1&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6699358</ArticleId><ArticleId IdType="pubmed">31467701</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang G.C., Talor M.V., Rose N.R. Thyroid autoantibodies are associated with a reduced prevalence of frailty in community-dwelling older women. J&#xa0;Clin Endocrinol Metab. 2010;95(3):1161&#x2013;1168.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2841533</ArticleId><ArticleId IdType="pubmed">20061418</ArticleId></ArticleIdList></Reference><Reference><Citation>Durelli L., Ferrero B., Oggero A. Thyroid function and autoimmunity during interferon beta-1b treatment: a multicenter prospective study. J&#xa0;Clin Endocrinol Metab. 2001;86(8):3525&#x2013;3532.</Citation><ArticleIdList><ArticleId IdType="pubmed">11502774</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y., Teng D., Shan Z. Antithyroperoxidase and antithyroglobulin antibodies in a five-year follow-up survey of populations with different iodine intakes. J&#xa0;Clin Endocrinol Metab. 2008;93(5):1751&#x2013;1757.</Citation><ArticleIdList><ArticleId IdType="pubmed">18270254</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>